Nitric oxide selectively decreases interferon-γ expression by activated human T lymphocytes via a cGMP-independent mechanism

被引:27
作者
Roozendaal, R
Vellenga, E
Postma, DS
De Monchy, JGR
Kauffman, HF
机构
[1] Univ Groningen Hosp, Div Allergol, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen Hosp, Div Haematol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen Hosp, Div Pulmonol, NL-9713 GZ Groningen, Netherlands
关键词
D O I
10.1046/j.1365-2567.1999.00895.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of exogenous nitric oxide (NO) on the expression of interleukin (IL)-2, IL-4, IL-5 and interferon-gamma (IFN-gamma) by freshly isolated human T lymphocytes was investigated. The presence of NO, generated from any of the NO-donor compounds, S-nitroso-N-acetyl-D,L-penicillamine (NAP), DPTA-nonoate (DPTA) or DETA-nonoate (DETA), added 15 min prior to T-cell stimulation (for 24 hr) with anti-CD3/anti-CD28 monoclonal antibodies (mAbs), resulted in up to 50% inhibition of IL-4, IL-5 and IFN-gamma secretion. In contrast, IL-2 secretion was not inhibited. Using the guanylate cyclase inhibitor, LY83583, it was shown that the inhibition of IL-4 and IL-5 was cGMP dependent, whereas additional mechanisms mediated the inhibition of IFN-gamma. Exposure of T cells to the NO-donor compounds for 24 hr prior to stimulation resulted in a more pronounced inhibition of IFN-gamma secretion by DPTA and DETA (P < 0.01), despite the fact that NO generation could no longer be detected. Under these conditions, IL-4 secretion was not inhibited and IL-5 secretion was inhibited to a lesser extent(P < 0.01 for SNAP and DPTA, P > 0.05 for DETA). IL-2 secretion was inhibited after 24 hr of preincubation with the NO-donor compounds, whereas it was not directly affected by NO. The increased inhibitory effects on IFN-gamma and IL-2 secretion could not be accounted for by the antiproliferative effects of the NO-donor compounds, which were diminished after 24 hr of preincubation relative to 15 min of preincubation. For IFN-gamma, the inhibition was at least partially effected at the transcriptional level as shown by decreased mRNA accumulation. These data show that NO can modulate the balance between the expression, by human T-lymphocytes, of T helper 1- and T helper 2-type cytokines, through selective and persistent inhibition of the expression of IFN-gamma via a cGmP-independent mechanism.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 32 条
[1]  
ALVING K, 1993, EUR RESPIR J, V6, P1368
[2]   NITRIC-OXIDE AND ASTHMATIC INFLAMMATION [J].
BARNES, PJ ;
LIEW, FY .
IMMUNOLOGY TODAY, 1995, 16 (03) :128-130
[3]   Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells [J].
Bauer, H ;
Jung, T ;
Tsikas, D ;
Stichtenoth, DO ;
Frolich, JC ;
Neumann, C .
IMMUNOLOGY, 1997, 90 (02) :205-211
[4]  
Bingisser RM, 1998, J IMMUNOL, V160, P5729
[5]   Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal [J].
Borger, P ;
Vellenga, E ;
Gringhuis, SI ;
Timmerman, JAB ;
Lummen, C ;
Postma, DS ;
Kauffman, HF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (02) :231-240
[6]   POSITIVE SELF REGULATION OF CYTO-TOXICITY IN HUMAN NATURAL-KILLER CELLS BY PRODUCTION OF INTERFERON UPON EXPOSURE TO INFLUENZA AND HERPES VIRUSES [J].
DJEU, JY ;
STOCKS, N ;
ZOON, K ;
STANTON, GJ ;
TIMONEN, T ;
HERBERMAN, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (04) :1222-1234
[7]   POTENTIATION OF ADENYLYL-CYCLASE IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY CELL-ACTIVATING STIMULI [J].
DOOPER, MWSM ;
HOEKSTRA, Y ;
TIMMERMANS, A ;
DEMONCHY, JGR ;
KAUFFMAN, HF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) :289-294
[8]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[9]   REGULATION AND BIOLOGICAL FUNCTION OF HELMINTH-INDUCED CYTOKINE RESPONSES [J].
FINKELMAN, FD ;
PEARCE, EJ ;
URBAN, JF ;
SHER, A .
IMMUNOPARASITOLOGY TODAY-A COMBINED ISSUE OF IMMUNOLOGY TODAY AND PARASITOLOGY TODAY, 1991, (03) :A62-A66
[10]  
FIRESTEIN GS, 1989, J IMMUNOL, V143, P518